Dinoprostone


Thông tin thuốc gốc
Chỉ định và Liều dùng
Extra-amniotic
Pregnancy termination in the 2nd trimester
Adult: Instill 1 mL via suitable foley catheter followed by 1-2 mL at 2 hr intervals according to patient's response.

Intracervical
Cervical priming, induction and augmentation of labour
Adult: As cervical gel: Insert 0.5 mg into the cervical canal, may be repeated at 6 hr interval, if needed. Max: 1.5 mg/24 hr.

Intravenous
Pregnancy termination in the 2nd trimester
Adult: 2.5 mcg/min via infusion over 30 min, then maintain or increase to 5 mcg/min. Maintain for at least 4 hr before increasing further.

Vaginal
Labour induction
Adult: As vag gel: 1 mg (or 2 mg in primigravid patient w/ unfavourable induction features) inserted into the posterior fornix, followed by 1-2 mg after 6 hr, if needed. Max: 3 mg (or 4 mg in unfavourable primigravid patient) per course. As vag tab: 3 mg inserted high into the posterior fornix, followed by a further 3 mg after 6-8 hr, if necessary. Max: 6 mg per course.

Vaginal
Pregnancy termination in the 2nd trimester
Adult: As vag supp: Insert 1 supp (20 mg) high into the posterior fornix, repeat at 3-5 hr interval until abortion occurs, for up to 2 days.

Vaginal
Cervical priming, induction and augmentation of labour
Adult: As vag device or insert delivering 0.3 mg/hr: Administer 1 vag device/insert (10 mg) high into posterior fornix and remove when cervical ripening is complete, or after 12-24 hr (depending on product) if cervical ripening is insufficient.
Hướng dẫn pha thuốc
IV: Dilute w/ appropriate volume of NaCl 0.9% or dextrose 5% to prepare a soln containing 5 mcg/mL. Extra-amniotic:Dilute w/ 50 mL of the diluent provided to prepare a soln containing 100 mcg/mL.
Chống chỉ định
Acute or history of pelvic inflammatory disease, vag infections or cervicitis, placenta praevia or unexplained vag bleeding, history of major uterine surgery or caesarean section, cephalopelvic disproportion, foetal malpresentation, foetal distress, grand multiparae, history of traumatic delivery, ruptured membranes. Active cardiac, pulmonary, renal or hepatic disease.
Thận trọng
Patient w/ compromised uteri, asthma, glaucoma, raised intraocular pressure, HTN or CV disease, epilepsy, gestational diabetes, hypothyroidism. Compromised cardiac, hepatic, or renal function.
Tác dụng không mong muốn
Significant: Rarely, disseminated intravascular coagulation (DIC).
CV: HTN.
GI: Diarrhoea, nausea, vomiting.
Resp: Asthma, bronchospasm.
Genitourinary: Uterine hypertonus, uterine rupture, abruptio placenta, pulmonary amniotic fluid embolism, rapid cervical dilatation, vag warmth, irritation, and pain.
Musculoskeletal: Back pain.
Dermatologic: Rash.
Immunologic: Anaphylactoid reactions including shock.
Others: Fever.
Potentially Fatal: Cardiac arrest.
Chỉ số theo dõi
Monitor foetal heart rate, uterine activity, progression of cervical dilation and effacement (gel, insert); confirmation of foetal death (supp).
Quá liều
Symptoms: Uterine hypercontractility, uterine hypertonus. Management: Conservative treatment (including change in maternal position or admin of oxygen); if not effective, β-adrenergic agents may be given.
Tương tác
Potentiates the uterotonic effect of oxytocic drugs.
Tác dụng
Description:
Mechanism of Action: Dinoprostone, a prostaglandin E2, stimulates uterine smooth muscle, thereby inducing uterine contractions similar to those produced by the body during spontaneous labour. It also promotes cervical ripening through activation of the collagenase enzyme which is responsible for digestion of some of the structural collagen network in the cervix. This results in cervical smooth muscle relaxation, allowing dilation and passage of the foetus through the birth canal.
Onset: W/in 10 min (vag supp).
Duration: 2-3 hr (vag supp); 0.3 mg/hr over 12 hr (vag insert).
Pharmacokinetics:
Absorption: Slowly absorbed (vag supp). Time to peak plasma concentration: 30-45 min (cervical gel).
Distribution: Rapidly distributed (IV). Diffuses into the maternal blood. Enters breast milk.
Metabolism: Extensively metabolised in the lungs, forming metabolites which are further metabolised in the liver and kidney.
Excretion: Mainly via urine; faeces (small amounts). Elimination half-life: 2.5-5 min.
Đặc tính

Chemical Structure Image

Source: National Center for Biotechnology Information. PubChem Database. Dinoprostone, CID=5280360, https://pubchem.ncbi.nlm.nih.gov/compound/Dinoprostone (accessed on Jan. 21, 2020)

Bảo quản
Soln: Store at 4°C. Gel: Store between 2-8°C. Vag supp: Store below -20°C. Vag insert: Store between -20 to -10°C.
Phân loại MIMS
Thuốc tác dụng lên tử cung
Phân loại ATC
G02AD02 - dinoprostone ; Belongs to the class of prostaglandins. Used to induce abortion or augment labour and to minimize blood loss from the placental site.
Tài liệu tham khảo
Anon. Dinoprostone. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 03/11/2016.

Buckingham R (ed). Dinoprostone. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 03/11/2016.

Cervidil Insert (Ferring Pharmaceuticals Inc). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 03/11/2016.

Joint Formulary Committee. Dinoprostone. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 03/11/2016.

McEvoy GK, Snow EK, Miller J et al (eds). Dinoprostone. AHFS Drug Information (AHFS DI) [online]. American Society of Health-System Pharmacists (ASHP). https://www.medicinescomplete.com. Accessed 03/11/2016.

Prepidil Gel (Pharmacia and Upjohn Company). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 03/11/2016.

Prostin E2 Suppository (Pharmacia and Upjohn Company). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 03/11/2016.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Dinoprostone từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2024 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
  • Cerviprime
  • Propess
  • Prostine E2
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in